Epizyme (EPZM) PT Lowered to $10 at Morgan Stanley
Tweet
Share
E-mailGet Alerts EPZM Hot Sheet
Price: $1.47 --0%
Rating Summary:
8 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
8 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
Morgan Stanley analyst David Lebowitz lowered the price target on Epizyme (NASDAQ: EPZM) to $10.00 (from $11.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Quest Diagnostics (DGX) PT Raised to $145 at Evercore ISI
- Morgan Stanley Downgrades ICICI Prudential Life Insurance Co Ltd. (IPRU:IN) to Equalweight
- JPMorgan Upgrades Samsung SDS Co Ltd (018260:KS) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
